- Home
- IMMP vs LAES Comparison
IMMP vs LAES Comparison
Compare IMMP & LAES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- LAES
- Stock Information
- Founded
- IMMP 1987
- LAES 2022
- Country
- IMMP Australia
- LAES Switzerland
- Employees
- IMMP N/A
- LAES N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- LAES Semiconductors
- Sector
- IMMP Health Care
- LAES Technology
- Exchange
- IMMP Nasdaq
- LAES Nasdaq
- Market Cap
- IMMP 304.0M
- LAES 307.1M
- IPO Year
- IMMP N/A
- LAES N/A
- Fundamental
- Price
- IMMP $1.78
- LAES $3.32
- Analyst Decision
- IMMP Buy
- LAES Strong Buy
- Analyst Count
- IMMP 2
- LAES 1
- Target Price
- IMMP $8.50
- LAES $6.00
- AVG Volume (30 Days)
- IMMP 81.1K
- LAES 13.7M
- Earning Date
- IMMP 03-25-2025
- LAES 03-24-2025
- Dividend Yield
- IMMP N/A
- LAES N/A
- EPS Growth
- IMMP N/A
- LAES N/A
- EPS
- IMMP N/A
- LAES N/A
- Revenue
- IMMP $3,019,249.00
- LAES $20,135,000.00
- Revenue This Year
- IMMP N/A
- LAES N/A
- Revenue Next Year
- IMMP $20.28
- LAES N/A
- P/E Ratio
- IMMP N/A
- LAES N/A
- Revenue Growth
- IMMP 24.11
- LAES N/A
- 52 Week Low
- IMMP $1.65
- LAES $0.29
- 52 Week High
- IMMP $3.34
- LAES $11.00
- Technical
- Relative Strength Index (RSI)
- IMMP 41.69
- LAES 52.81
- Support Level
- IMMP $1.65
- LAES $2.40
- Resistance Level
- IMMP $1.88
- LAES $2.94
- Average True Range (ATR)
- IMMP 0.10
- LAES 0.39
- MACD
- IMMP -0.01
- LAES 0.07
- Stochastic Oscillator
- IMMP 41.94
- LAES 95.00
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. Its vaultIC range offers a complete set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.